| Dec 25 | |
|---|---|
| Income Statement | |
| Total Revenue | $ 0.00 |
| Gross Profit | $ 0.00 |
| Operating Income | $ -109.13K |
| EBITDA | $ -109.12K |
| Net Income | $ -127.51K |
| Balance Sheet | |
| Cash & Short-Term Investments | $ 1.32K |
| Total Assets | $ 111.32K |
| Total Debt | $ 152.22K |
| Net Debt | $ 150.91K |
| Total Liabilities | $ 793.56K |
| Stockholders' Equity | $ -682.25K |
| Cash Flow | |
| Free Cash Flow | $ -88.37K |
| Operating Cash Flow | $ -88.37K |
| Investing Cash Flow | $ 0.00 |
| Financing Cash Flow | $ 87.97K |
Synbio International Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.